TNFA שווי כולל של נכסי החברה TNF Pharma

TNF Pharmaceuticals (TNFA) is optimizing the study of inflammatory processes through AI analytics, reducing the need for a large staff of biologists. A stable core of scientists ensures the development of long-term projects without personnel risks. The asset's market valuation dynamics show that total assets amount to 33.14. Management relies on a flexible structure focused on R&D, while the level of financial flow disclosure remains standard for the public sector.

TNF Pharmaceuticals' development of unique anti-aging molecules makes the valuation of the company's financial assets a key indicator of the resource base for clinical trials. This metric reflects the aggregate of assets and liabilities, calculated inversely via return on assets (ROA), allowing investors to compare the actual scale of the business with market expectations and determine the issuer's reliability within the biotechnology sector.